Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06282770 · ClinicalTrials.gov registry record · NA

Photobiomodulation for Lower Back Pain Post Spinal Fusion and Decompression Surgery

A NA study of Spinal Fusion and Chronic Lower Back Pain, sponsored by University of California, Los Angeles.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
2
Study locations

NCT06282770: Recruiting NA study of Spinal Fusion and Chronic Lower Back Pain, sponsored by University of California, Los Angeles.

NCT06282770 is a NA study of Spinal Fusion and Chronic Lower Back Pain that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 80 participants, below the 479-participant average among 19 other Spinal Fusion trials with a reported enrollment target (83% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06282770, a NA study of Spinal Fusion and Chronic Lower Back Pain, is actively recruiting participants, sponsored by University of California, Los Angeles.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
2
Study locations

Study Summary

After spinal fusion and decompression surgery there is a possible risk of developing chronic back pain. After surgery there is typically inflammation around the operation site and this inflammation can be painful and debilitating to patients. Many possible treatment plans have been incorporated to assist the patient with recovery - notably medications, physical therapy, and braces. However, few studies have looked at laser diodes that utilize high-power laser lights that are aimed at decreasing pain and inflammation. Investigators aim to look compare patients using a back brace with laser diodes within versus those who wear a normal brace used as a placebo. Investigators will also assess the patient's surgical wound to monitor the progression of wound healing while using the brace.

Primary Outcome

Subjects will fill out two questionnaires related to their pain and quality of life before and after surgery with laser diode brace photobiomodulation therapy. The first survey is the Visual Analog Scale (VAS), which asks subjects to state how good or bad their current health state is on a scale of 0-100, 1 being the worst imaginable health state and 100 being the best imaginable health state. There are two additional questions that ask subjects to provide a rate their current back and leg pain

Conditions Studied

Spinal Fusion Chronic Lower Back Pain

Interventions

  • DEVICE Laser Diode Brace
  • DEVICE Sham Laser Diode Brace

Study Locations (2)

California

  • Semel Institute of Neuroscience at UCLA - Los Angeles
  • UCLA Clinical and Translational Research Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2023-07-01
Est. Completion 2026-07-01
Phase NA
University of California, Los Angeles

897 total trials

What NCT06282770 shows while recruiting

NCT06282770 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 479-participant average among 19 other Spinal Fusion trials with a reported enrollment target (83% lower).

The record links to 2 conditions, with Spinal Fusion appearing as the primary indexed condition, and to 2 interventions - of which Laser Diode Brace is the first listed.

NCT06282770 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06282770 about?

NCT06282770 is a clinical study titled "Photobiomodulation for Lower Back Pain Post Spinal Fusion and Decompression Surgery". After spinal fusion and decompression surgery there is a possible risk of developing chronic back pain. After surgery there is typically inflammation around the operation site and this inflammation can be painful and debilitating to patients. Many possible treatment plans have been incorporated to ...

What is the current status of trial NCT06282770?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-07-01. Estimated completion is 2026-07-01.

What conditions does trial NCT06282770 study?

This clinical trial studies the following conditions: Spinal Fusion, Chronic Lower Back Pain.

What interventions are being tested in trial NCT06282770?

The interventions under investigation include: Laser Diode Brace (DEVICE), Sham Laser Diode Brace (DEVICE).

Who is sponsoring clinical trial NCT06282770?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06282770 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Spinal Fusion

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06282770's enrollment target sits among peer trials

80 12th of 19 higher than 8 of 19 other Spinal Fusion trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Fusion trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06282770

Source: ClinicalTrials.gov NCT06282770, the US trial registry maintained by the National Library of Medicine. NCT06282770 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.